1. Home
  2. GH vs COKE Comparison

GH vs COKE Comparison

Compare GH & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$85.12

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Logo Coca-Cola Consolidated Inc.

COKE

Coca-Cola Consolidated Inc.

HOLD

Current Price

$202.17

Market Cap

13.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
GH
COKE
Founded
2011
1902
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
13.3B
13.5B
IPO Year
2018
1994

Fundamental Metrics

Financial Performance
Metric
GH
COKE
Price
$85.12
$202.17
Analyst Decision
Strong Buy
Analyst Count
20
0
Target Price
$117.80
N/A
AVG Volume (30 Days)
1.7M
446.5K
Earning Date
04-29-2026
04-29-2026
Dividend Yield
N/A
0.48%
EPS Growth
6.74
156.81
EPS
N/A
1.21
Revenue
$982,021,000.00
$7,228,055,000.00
Revenue This Year
$33.40
N/A
Revenue Next Year
$28.55
N/A
P/E Ratio
N/A
$174.19
Revenue Growth
32.88
4.76
52 Week Low
$36.36
$105.21
52 Week High
$120.74
$1,433.97

Technical Indicators

Market Signals
Indicator
GH
COKE
Relative Strength Index (RSI) 34.90 56.10
Support Level $82.26 $109.84
Resistance Level $103.16 $209.24
Average True Range (ATR) 3.94 6.20
MACD 0.07 -1.73
Stochastic Oscillator 20.02 11.42

Price Performance

Historical Comparison
GH
COKE

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

About COKE Coca-Cola Consolidated Inc.

Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other and . Key revenue is generated from Nonalcoholic Beverages.

Share on Social Networks: